This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

AI x Next Generation Clinical Trials
April 22-23, 2026
Sheraton Boston HotelBoston, MA

Kim Wilkinson, PhD
Associate Director at Alexion Pharmaceuticals
Speaker

Profile

Kim Wilkinson, PhD, is an Associate Director of Medical Writing at Alexion, AstraZeneca Rare Disease, with experience integrating artificial intelligence into clinical regulatory workflows. She focuses on practical applications of generative AI in medical writing, including content generation, data summarization, translation, and document analytics, and has shared this work through an AI-focused strategic thinking workshop at DIA. She is also involved in building AI-powered tools to improve efficiency and document quality, informed by her completion of the AstraZeneca Platinum AI certification program, and supports responsible adoption of these technologies as an internal AI Amplifier and mentor.

Agenda Sessions

  • Panel: Intelligent Documentation: AI for Medical Writing and Reporting

    1:00pm